FC
IDXX icon

Financial Consulate’s Idexx Laboratories IDXX Stock Holding History

Financial Consulate’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-572
Closed -$201K – 121
2022
Q2 		$201K Buy
+572
New +$233K 0.09% 119
2022
Q1 		– Sell
-305
Closed -$201K – 138
2021
Q4 		$201K Buy
+305
New +$191K 0.07% 135
2021
Q3 		– Sell
-326
Closed -$206K – 134
2021
Q2 		$206K Buy
+326
New +$180K 0.07% 126

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Financial Consulate's IDXX Position: Q3 2022 in Review

Financial Consulate sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 572 shares — an estimated $201K sold.

Financial Consulate first reported a position in IDXX in Q2 2021 and held it in 3 quarters. The position peaked at $206K in Q2 2021. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Financial Consulate reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
  • Financial Consulate sold 572 Idexx Laboratories shares in Q3 2022, an estimated $201K.
  • Financial Consulate first reported a position in Idexx Laboratories in Q2 2021 and held it in 3 quarters.
  • Financial Consulate's Idexx Laboratories position peaked at $206K in Q2 2021.
  • 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Financial Consulate's 13F filing for Q3 2022, filed 20 Oct 2022.